• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾功能与外周动脉疾病风险:社区动脉粥样硬化风险(ARIC)研究结果

Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study.

作者信息

Wattanakit Keattiyoat, Folsom Aaron R, Selvin Elizabeth, Coresh Josef, Hirsch Alan T, Weatherley Beth D

机构信息

Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Suite 300, 1300 South Second Street, Minneapolis, MN 55454-1015, USA.

出版信息

J Am Soc Nephrol. 2007 Feb;18(2):629-36. doi: 10.1681/ASN.2005111204. Epub 2007 Jan 10.

DOI:10.1681/ASN.2005111204
PMID:17215445
Abstract

Chronic kidney disease (CKD) is associated with an increased risk for cardiovascular disease, but its association with peripheral arterial disease (PAD) is unclear. With the use of data from the Atherosclerosis Risk in Communities (ARIC) Study, 14,280 middle-aged adults were categorized on the basis of estimated GFR >/=90, 60 to 89, and 15 to 59 ml/min per 1.73 m(2) for normal kidney function, mildly decreased kidney function, and stages 3 to 4 CKD, respectively. Incident PAD was defined as a new onset of ankle-brachial index <0.9 assessed at regular examinations, new intermittent claudication assessed by annual surveillance, or PAD-related hospital discharges. Incidence rates and relative risks (RR) for PAD were compared across these categories. During a mean follow-up time of 13.1 yr (186,616 person-years), 1016 participants developed PAD. The incidence rates per 1000 person-years were 4.7, 4.9, and 8.6 for the normal kidney function, mildly decreased kidney function, and CKD groups, respectively. Compared with participants with normal kidney function, the age-, gender-, race-, and ARIC field center-adjusted RR for PAD was 1.04 (95% confidence interval [CI] 0.91 to 1.18) for those with mildly decreased kidney function and 1.82 (95% CI 1.34 to 2.47) for those with CKD. After additional adjustment for cardiovascular disease risk factors, an increase in risk for incident PAD still was observed in participants with CKD, with a multivariable adjusted RR of 1.56 (95% CI 1.13 to 2.14). Patients with CKD are at increased risk for incident PAD. Development of strategies for screening and prevention of PAD in this high-risk population seems warranted.

摘要

慢性肾脏病(CKD)与心血管疾病风险增加相关,但其与外周动脉疾病(PAD)的关联尚不清楚。利用社区动脉粥样硬化风险(ARIC)研究的数据,14280名中年成年人根据估算的肾小球滤过率(GFR)进行分类,分别为每1.73平方米体表面积肾小球滤过率≥90、60至89以及15至59毫升/分钟,对应正常肾功能、轻度肾功能减退和3至4期CKD。新发PAD定义为定期检查时踝臂指数<0.9的新发情况、年度监测评估的新间歇性跛行或与PAD相关的住院出院。比较了这些类别中PAD的发病率和相对风险(RR)。在平均13.1年的随访时间(186616人年)内,1016名参与者发生了PAD。正常肾功能、轻度肾功能减退和CKD组每1000人年的发病率分别为4.7、4.9和8.6。与肾功能正常的参与者相比,肾功能轻度减退者发生PAD的年龄、性别、种族和ARIC现场中心校正RR为1.04(95%置信区间[CI]0.91至1.18);CKD患者为1.82(95%CI 1.34至2.47)。在进一步调整心血管疾病危险因素后,仍观察到CKD参与者发生PAD的风险增加,多变量校正RR为1.56(95%CI 1.13至2.14)。CKD患者发生PAD的风险增加。在这一高危人群中制定PAD筛查和预防策略似乎是必要的。

相似文献

1
Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study.肾功能与外周动脉疾病风险:社区动脉粥样硬化风险(ARIC)研究结果
J Am Soc Nephrol. 2007 Feb;18(2):629-36. doi: 10.1681/ASN.2005111204. Epub 2007 Jan 10.
2
Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study.传统和非传统风险因素可预测慢性肾脏病患者的冠心病:社区动脉粥样硬化风险研究结果
J Am Soc Nephrol. 2005 Feb;16(2):529-38. doi: 10.1681/ASN.2004080656. Epub 2004 Dec 29.
3
Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study.肾功能减退作为新发心力衰竭的危险因素:社区动脉粥样硬化风险(ARIC)研究
J Am Soc Nephrol. 2007 Apr;18(4):1307-15. doi: 10.1681/ASN.2006101159. Epub 2007 Mar 7.
4
Cardiovascular risk among adults with chronic kidney disease, with or without prior myocardial infarction.患有慢性肾脏病的成年人的心血管风险,无论其既往有无心肌梗死。
J Am Coll Cardiol. 2006 Sep 19;48(6):1183-9. doi: 10.1016/j.jacc.2006.05.047. Epub 2006 Aug 28.
5
Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults.非糖尿病成年人中的代谢综合征与慢性肾脏病风险
J Am Soc Nephrol. 2005 Jul;16(7):2134-40. doi: 10.1681/ASN.2005010106. Epub 2005 May 18.
6
Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study.美国印第安人中的代谢综合征与慢性肾脏病的发展:强心研究
Am J Kidney Dis. 2008 Jan;51(1):21-8. doi: 10.1053/j.ajkd.2007.09.014.
7
Combined role of reduced estimated glomerular filtration rate and microalbuminuria on the prevalence of peripheral arterial disease.估算肾小球滤过率降低和微量白蛋白尿对周围动脉疾病患病率的联合作用。
Am J Cardiol. 2009 Nov 15;104(10):1446-51. doi: 10.1016/j.amjcard.2009.06.068.
8
Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the National Health and Nutrition Examination Survey 1999-2004.60岁及以上人群外周动脉疾病的患病率及危险因素:来自1999 - 2004年国家健康与营养检查调查的数据
J Am Geriatr Soc. 2007 Apr;55(4):583-9. doi: 10.1111/j.1532-5415.2007.01123.x.
9
Peripheral arterial disease in patients with stages IV and V chronic renal failure.IV期和V期慢性肾衰竭患者的外周动脉疾病
Nephrol Dial Transplant. 2006 Dec;21(12):3525-31. doi: 10.1093/ndt/gfl470. Epub 2006 Aug 29.
10
Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIC) Study.肾功能和贫血作为冠心病及死亡率的危险因素:社区动脉粥样硬化风险(ARIC)研究
Am Heart J. 2006 Feb;151(2):492-500. doi: 10.1016/j.ahj.2005.03.055.

引用本文的文献

1
Serum Endocan Levels as a Risk Factor for Peripheral Artery Disease in Non-Dialysis Patients with Chronic Kidney Disease Stages 3-5.血清内脂素水平作为3-5期慢性肾脏病非透析患者外周动脉疾病的危险因素
Medicina (Kaunas). 2025 Mar 24;61(4):577. doi: 10.3390/medicina61040577.
2
Current Prognostic Biomarkers for Peripheral Arterial Disease: A Comprehensive Systematic Review of the Literature.外周动脉疾病的当前预后生物标志物:文献的全面系统综述
Metabolites. 2025 Mar 25;15(4):224. doi: 10.3390/metabo15040224.
3
Chronic Kidney Disease and Risk of Mortality and Major Adverse Limb Events After Femoral Artery Endovascular Revascularization for Peripheral Artery Disease: The Boston Femoral Artery Endovascular Revascularization Outcomes (Boston FAROUT) Study.
慢性肾脏病与外周动脉疾病行股动脉血管腔内血运重建术后的死亡率及主要肢体不良事件风险:波士顿股动脉血管腔内血运重建术结局(Boston FAROUT)研究
Catheter Cardiovasc Interv. 2025 Apr;105(5):1214-1221. doi: 10.1002/ccd.31447. Epub 2025 Feb 10.
4
Associations of Metabolic Dysfunction-Associated Fatty Liver Disease With Peripheral Artery Disease: Prospective Analysis in the UK Biobank and ARIC Study.代谢功能障碍相关脂肪性肝病与外周动脉疾病的相关性:英国生物库和 ARIC 研究的前瞻性分析。
J Am Heart Assoc. 2024 Nov 19;13(22):e035265. doi: 10.1161/JAHA.124.035265. Epub 2024 Nov 15.
5
Blood Hemoglobin Concentrations and the Incidence of Lower Extremity Peripheral Arterial Disease in Patients Undergoing Hemodialysis: 10-Year Outcomes of the Q-Cohort Study.血液血红蛋白浓度与血液透析患者下肢外周动脉疾病的发生:Q 队列研究的 10 年结果。
J Am Heart Assoc. 2024 Aug 6;13(15):e033853. doi: 10.1161/JAHA.123.033853. Epub 2024 Aug 5.
6
Efficacy of CHADS-VASc scores in predicting chronic kidney disease risk in patients treated in cardiac intensive care units.CHADS-VASc评分对心脏重症监护病房患者慢性肾脏病风险的预测效能
Heliyon. 2024 Jun 5;10(13):e32452. doi: 10.1016/j.heliyon.2024.e32452. eCollection 2024 Jul 15.
7
Peripheral artery disease, chronic kidney disease, and recurrent admissions for acute decompensated heart failure: The ARIC study.外周动脉疾病、慢性肾脏病和急性失代偿性心力衰竭的反复入院:ARIC 研究。
Atherosclerosis. 2024 Aug;395:118521. doi: 10.1016/j.atherosclerosis.2024.118521. Epub 2024 Jun 12.
8
Urinary vanin-1 as a novel biomarker for survival in peripheral artery disease.尿 vanin-1 作为外周动脉疾病生存的新型生物标志物。
Vasc Med. 2024 Aug;29(4):390-397. doi: 10.1177/1358863X241240428. Epub 2024 Apr 12.
9
Granulocyte Colony-Stimulating Factor Improves Endothelial Progenitor Cell-Mediated Neovascularization in Mice with Chronic Kidney Disease.粒细胞集落刺激因子改善慢性肾脏病小鼠中内皮祖细胞介导的新生血管形成。
Pharmaceutics. 2023 Sep 25;15(10):2380. doi: 10.3390/pharmaceutics15102380.
10
Protective Effects of Statins on Limb and Cardiovascular Outcomes in Patients with Peripheral Artery Disease and End-Stage Renal Disease.他汀类药物对周围动脉疾病和终末期肾病患者肢体及心血管结局的保护作用
Acta Cardiol Sin. 2023 Sep;39(5):755-764. doi: 10.6515/ACS.202309_39(5).20230118A.